Table 1.
Comparison of baseline characteristics of patient cohort in the three calculation methods
| RWTPW | RWTIVS+PW | RWTIVS | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Low Group (≤ 0.32,n = 476) | High Group (> 0.32,n = 390) | P value | Low Group (≤ 0.33,n = 509) | High Group (> 0.33,n = 357) | P Value | Low Group (≤ 0.33,n = 456) | High Group (> 0.33,n = 410) | P Value | |
| Age(years) | 64.71(55–74) | 63.1(53–74) | 0.114 | 64.3(54–74) | 63.37(54–73) | 0.285 | 64.71(54–75) | 63.07(53.5–72.5) | 0.039 |
| Male sex,n(%) | 353(79.9) | 337(81.0) | 0.673 | 372(80.0) | 318(80.9) | 0.736 | 337(79.5) | 353(81.3) | 0.494 |
| Shock,n(%) | 29(6.6) | 18(4.3) | 0.151 | 29(6.2) | 18(4.6) | 0.288 | 27(6.4) | 20(4.6) | 0.257 |
| Bleeding,n(%) | 15(3.7) | 7(1.8) | 0.089 | 11(2.6) | 11(2.9) | 0.790 | 11(2.8) | 11(2.6) | 0.873 |
| History of cancer,n(%) | 11(2.7) | 4(1.0) | 0.073 | 10(2.3) | 5(1.3) | 0.281 | 9(2.3) | 6(1.4) | 0.361 |
| Hypertension,n(%) | 254(57.5) | 274(65.9) | 0.011 | 263(56.6) | 265(67.4) | 0.001 | 235(55.4) | 293(67.5) | < 0.001 |
| Diabetes,n(%) | 116(26.2) | 111(26.7) | 0.884 | 101(21.7) | 126(32.1) | 0.001 | 92(21.7) | 135(31.1) | 0.002 |
| Hyperlipidemia,n(%) | 64(14.5) | 69(16.6) | 0.394 | 67(14.4) | 66(16.8) | 0.336 | 59(13.9) | 74(17.1) | 0.205 |
| Prior stroke,n(%) | 60(13.6) | 53(12.7) | 0.718 | 64(13.8) | 49(12.5) | 0.576 | 56(13.2) | 57(13.1) | 0.974 |
| Smoking,n(%) | 256(57.9) | 226(54.3) | 0.289 | 272(58.5) | 210(53.4) | 0.137 | 240(56.6) | 242(55.8) | 0.803 |
| Family history,n(%) | 18(5.6) | 8(2.7) | 0.069 | 17(5.0) | 9(3.2) | 0.283 | 14(4.6) | 12(3.8) | 0.616 |
| Systolic blood pressure(mmHg) | 120.09(105–132) | 124.67(110–139) | 0.001 | 120.65(106–132) | 124.28(110–139) | 0.012 | 120.71(106–132) | 123.87(109–138) | 0.035 |
| Heart rate(bpm) | 81.31(71–90) | 81.48(70–92) | 0.721 | 81.25(71–90) | 81.56(70–91) | 0.558 | 81.09(71–90) | 81.68(70–91) | 0.389 |
| Shock index | 0.70(0.57–0.79) | 0.67(0.55–0.76) | 0.030 | 0.69(0.57–0.78) | 0.68(0.55–0.78) | 0.147 | 0.69(0.56–0.78) | 0.68(0.55–0.78) | 0.500 |
| Creatinine(umol/L) | 80.37(62–86) | 78.17(61–86) | 0.430 | 79.37(62–86) | 79.07(61–85) | 0.371 | 79.80(62.5–86) | 78.67(61–85) | 0.378 |
| LDL-C(mmol/L) | 3.09(1.87–2.84) | 2.49(1.95–2.97) | 0.019 | 3.09(1.91–2.90) | 2.46(1.91–2.94) | 0.316 | 3.15(1.91–2.89) | 2.45(1.91–2.94) | 0.385 |
| LVEF(%) | 44.53(40–49) | 46.47(42–50) | < 0.001 | 44.06(40–48) | 47.15(44–50) | < 0.001 | 43.59(39–48) | 47.34(45–50) | < 0.001 |
| LVDd(cm) | 5.54(5.26–5.72) | 5.18(3.7–4.1) | < 0.001 | 5.53(5.25–5.70) | 5.16(4.90–5.40) | < 0.001 | 5.55(5.3–5.74) | 5.17(4.91–5.4) | < 0.001 |
| IVSth(cm) | 0.83(0.75–0.9) | 0.97(0.85–1.05) | < 0.001 | 0.81(0.75–0.86) | 1.00(0.90–1.05) | < 0.001 | 0.80(0.75–0.85) | 1.0(0.90–1.05) | < 0.001 |
| PWth(cm) | 0.81(0.8–0.85) | 0.95(0.89–1) | < 0.001 | 0.82(0.80–0.85) | 0.95(0.85–1.0) | < 0.001 | 0.83(0.80–0.88) | 0.92(0.82–1.0) | < 0.001 |
| LA(cm) | 4.09(3.75–4.2) | 3.95(3.7–4.1) | 0.020 | 4.07(3.75–4.2) | 3.96(3.75–4.14) | 0.237 | 4.09(3.77–4.2) | 3.96(3.74–4.15) | 0.048 |
| Anterior wall,n(%) | 216(51.9) | 188(42.5) | 0.006 | 242(52.0) | 162(41.2) | 0.002 | 250(59.0) | 154(35.5) | < 0.001 |
| Multivessel lesions,n(%) | 164(37.1) | 140(33.7) | 0.291 | 166(35.7) | 138(35.1) | 0.858 | 146(34.4) | 158(36.4) | 0.546 |
The continous variables were presented as mean ± SD or median(IQR)
LDL-C Low density lipoprotein cholesterol, LVEF Left ventricular ejection fraction, LVDd Left ventricular diameter at the end of diastole, IVSth Intraventricular septal thickness, PWth Posterior wall thickness, LA Left atrium